Top

Gepubliceerd in:

2012 | OriginalPaper | Hoofdstuk

21. Transcatheter Treatment of Coronary Artery Disease

Auteur : Robert F. Wilson, MD

Uitgeverij: Springer US

Abstract

This chapter describes the various methods of percutaneous coronary intervention (PCI), including balloon angioplasty, stenting, thrombectomy, and atherectomy, and the application of intravascular ultrasound. It also illustrates the use of PCI in special cases, as in acute coronary syndromes, acute myocardial infarction, chronic total occlusion, severe calcification of the coronary arteries, and aneurysmal disease. PCI is now the primary method of coronary revascularization. PCI originated as balloon angioplasty, first performed in humans by Andreas Gruntzig in 1978, but it has evolved into a variety of catheter-based methods to treat coronary disease [1]. PCI has revolutionized modern cardiovascular care, enabling patients with myocardial ischemia to be treated less invasively by avoiding a surgical approach. As experience accrued and the technology advanced, the number of patients and angiographic lesion subsets increased dramatically – up to the current era in which PCI is now more commonly performed than coronary artery bypass graft (CABG) surgery. When available and performed in experienced centers by well-trained, expert physicians and teams, it has become the procedure of choice for acute coronary syndromes, acute myocardial infarction, single-vessel coronary artery disease, and many patients with two- and three-vessel coronary artery disease. In addition, it has become the treatment of choice for saphenous vein bypass graft stenoses.

vorige hoofdstuk Nonatherosclerotic Ischemic Heart Disease

volgende hoofdstuk Surgical Treatment of Coronary Artery Disease

Andreas R, Grüntzig MD, Åke Senning MD, Siegenthaler WE. Nonoperative dilatation of coronary-artery stenosis — percutaneous transluminal coronary angioplasty. N Engl J Med. 1979;301:61–8.CrossRef

Tenaglia AN, Buller CE, Kisslo KB, Stack RS, Davidson CJ. Mechanisms of balloon angioplasty and directional coronary atherectomy as assessed by intracoronary ultrasound. J Am Coll Cardiol. 1992;20:685–91.PubMedCrossRef

Jain A, Demer LL, Raizner AE, Hartley CJ, Lewis JM, Roberts R. In vivo assessment of vascular dilatation during percutaneous transluminal coronary angioplasty. Am J Cardiol. 1987;60(13):988–92.PubMedCrossRef

Fischman DL, Leon MB, Baim DS, et al., Stent Restenosis Study Investigators. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med. 1994;331:496–501.CrossRef

Wilson RF, Marcus ML, Aylward PE, Talman CT, White CW. The effect of coronary angioplasty on coronary flow reserve. Circulation. 1988;77:873–85.PubMedCrossRef

Manyari DE, Knudtson M, Kloiber R, Roth D. Sequential thallium-201 myocardial perfusion studies after successful percutaneous transluminal coronary artery angioplasty: delayed resolution of exercise-induced scintigraphic abnormalities. Circulation. 1988;77:86–95.PubMedCrossRef

Writing Group for the Bypass Angioplasty Revascularization Investigation (BARI) Investigators. Five-year clinical and functional outcome comparing bypass surgery and angioplasty in patients with multivessel coronary disease. A multicenter randomized trial. JAMA. 1997;277:715–21.CrossRef

Coronary artery angiographic changes after PTCA: manual of operations NHLBI PTCA Registry. 1985;6:9.

Ellis SG, Vandormael MG, Cowley MJ, et al. Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Implications for patient selection. Multivessel Angioplasty Prognosis Study Group. Circulation. 1990;82:1193–202.PubMedCrossRef

10.

Goldstein JA, Casserly IP, Katsiyiannis WT, et al. Aortocoronary dissection complicating a percutaneous coronary intervention. J Invasive Cardiol. 2003;15:89–92.PubMed

11.

Eberli FR, Meier B. Restenosis after angioplasty: an Achilles’ heel well covered-up [editorial]. Eur Heart J. 1998;19:976–7.PubMed

12.

Schwartz RS, Henry TD. Pathophysiology of coronary artery restenosis. Rev Cardiovasc Med. 2002;3 suppl 5:S4–9.PubMed

13.

Kastrati A, Dibra A, Mehilli J, et al. Predictive factors of restenosis after coronary implantation of sirolimus- or paclitaxel-eluting stents. Circulation. 2006;113(19):2293–300. doi:10.1161/CIRCULATIONAHA.105.601823.PubMedCrossRef

14.

Serruys PW, de Jaegere P, Kiemeneij F, et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med. 1994;331:489–95.PubMedCrossRef

15.

Farb A, Weber DK, Kolodgie FD, Burke AP, Virmani R. Morphological predictors of restenosis after coronary stenting in humans. Circulation. 2002;105:2974–80.PubMedCrossRef

16.

Park DW, Kim YH, Yun SC, et al. Comparison of zotarolimus-eluting stents with sirolimus- and paclitaxel-eluting stents for coronary revascularization. J Am Coll Cardiol. 2010;56:1187–95.PubMedCrossRef

17.

Shishehbor MH, Goel SS, Kapadia SR, et al. Long-term impact of drug-eluting stents versus bare-metal stents on all-cause mortality. J Am Coll Cardiol. 2008;52:1041–8.PubMedCrossRef

18.

Iakovou T, Schmidt T, Bonizzoni E, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA. 2005;293:2126–30.PubMedCrossRef

19.

Kuchulakanti PK, Chu WW, Torguson R, et al. Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stents. Circulation. 2006;113:1108–13.PubMedCrossRef

20.

Nakazawa G, Finn AV, Joner M, et al. Delayed arterial healing and increased late stent thrombosis at culprit sites after drug-eluting stent placement for acute myocardial infarction patients: an autopsy study. Circulation. 2008;118:1138–45.PubMedCrossRef

21.

Porto I, Selvanayagam JB, Van Gaal WJ, et al. Plaque volume and occurrence and location of periprocedural myocardial necrosis after percutaneous coronary intervention: insights from delayed-enhancement magnetic resonance imaging, thrombolysis in myocardial infarction myocardial perfusion grade analysis, and intravascular ultrasound. Circulation. 2006;114(7):662–9.PubMedCrossRef

22.

Migliorini A, Stabile A, Rodriguez AE, et al., JETSTENT Trial Investigators.. Comparison of AngioJet rheolytic thrombectomy before direct infarct artery stenting with direct stenting alone in patients with acute myocardial infarction: the JETSTENT Trial. J Am Coll Cardiol. 2010;56:1298–306.CrossRef

23.

Vom Dahl J, Dietz U, Haager PK, et al. Rotational atherectomy does not reduce recurrent in-stent restenosis: results of the angioplasty versus rotational atherectomy for treatment of diffuse in-stent restenosis trial (ARTIST). Circulation. 2002;105:583–8.PubMedCrossRef

24.

Casserly IP. Orbital atherectomy – another tool in the art of peripheral arterial intervention. Catheter Cardiovasc Interv. 2009;73(3):413–4.PubMed

25.

Albiero R, Silber S, Di Mario C, et al. Cutting balloon versus conventional balloon angioplasty for the treatment of in-stent restenosis: results of the restenosis cutting balloon evaluation trial (RESCUT). J Am Coll Cardiol. 2004;43:943–9.PubMedCrossRef

26.

Sales FJ, Falcão BA, Falcão JL, et al. Evaluation of plaque composition by intravascular ultrasound “virtual histology:” the impact of dense calcium on the measurement of necrotic tissue. EuroIntervention. 2010;6:394–9.PubMedCrossRef

27.

Russo RJ, Silva PD, Teirstein PS, et al. AVID investigators: a randomized controlled trial of angiography versus intravascular ultrasound-directed bare-metal coronary stent placement (the AVID Trial). Circ Cardiovasc Interv. 2009;2:113–23.PubMedCrossRef

28.

Finn AV, Nakazawa G, Ladich E, Kolodgie FD, Virmani R. Does underlying plaque morphology play a role in vessel healing after drug-eluting stent implantation? JACC Cardiovasc Imaging. 2008;1:485–8.PubMedCrossRef

29.

Vlaar PJ, Svilaas T, Damman K, et al. Impact of pretreatment with clopidogrel on initial patency and outcome in patients treated with primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a systematic review. Circulation. 2008;118:1828–36.PubMedCrossRef

30.

Weisz G, Moses JW. Contemporary principles of coronary chronic total occlusion recanalization. Catheter Cardiovasc Interv. 2010;75 suppl 1:S21–7.PubMedCrossRef

31.

Paizis I, Manginas A, Voudris V, Pavlides G, Spargias K, Cokkinos DV. Percutaneous coronary intervention for chronic total occlusions: the role of side-branch obstruction. EuroIntervention. 2009;4:600–6.PubMedCrossRef

32.

Hodgson JM. Oh no, even stenting is affected by calcium [editorial]. Cathet Cardiovasc Diagn. 1996;38:236–7.PubMedCrossRef

33.

Rathore S, Matsuo H, Terashima M, et al. Rotational atherectomy for fibro-calcific coronary artery disease in drug eluting stent era: procedural outcomes and angiographic follow-up results. Catheter Cardiovasc Interv. 2010;75:919–27.PubMed

34.

Bajaj S, Parikh R, Hamdan A, Bikkina M. Covered-stent treatment of coronary aneurysm after drug-eluting stent placement: case report and literature review. Tex Heart Inst J. 2010;37:449–54.PubMed

35.

Baim DS, Wahr D, George B, et al. Saphenous vein graft Angioplasty Free of Emboli Randomized (SAFER) Trial investigators: randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts. Circulation. 2002;105(11):1285–90.PubMed

36.

Kelbaek H, Terkelsen CJ, Helqvist S, et al. Randomized comparison of distal protection versus conventional treatment in primary percutaneous coronary intervention: the drug elution and distal protection in ST-elevation myocardial infarction (DEDICATION) trial. J Am Coll Cardiol. 2008;51:899–905.PubMedCrossRef

37.

Roffi M, Mukherjee D. Current role of emboli protection devices in percutaneous coronary and vascular interventions. Am Heart J. 2009;157:263–70.PubMedCrossRef

38.

Stone GW, Rogers C, Hermiller J, et al. FilterWire EZ Randomized Evaluation Investigators: randomized comparison of distal protection with a filter-based catheter and a balloon occlusion and aspiration system during percutaneous intervention of diseased saphenous vein aorto-coronary bypass grafts. Circulation. 2003;108:548–53.PubMedCrossRef

39.

Mauri L, Cox D, Hermiller J, et al. The PROXIMAL trial: proximal protection during saphenous vein graft intervention using the Proxis embolic protection system: a randomized, prospective, multicenter clinical trial. J Am Coll Cardiol. 2007;50:1442–9.PubMedCrossRef

Titel: Transcatheter Treatment of Coronary Artery Disease
Auteur: Robert F. Wilson, MD
Uitgeverij: Springer US
Boek: Coronary Heart Disease
Print ISBN: 978-1-4614-1474-2

Elektronisch ISBN: 978-1-4614-1475-9

Copyright: 2012
DOI: https://doi.org/10.1007/978-1-4614-1475-9_21

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Abstract

Log in om toegang te krijgen